Clarification Needed Regarding Anti-Topoisomerase I as a Biomarker for Non-Small Cell Lung Cancer

Ann Thorac Surg. 2018 Sep;106(3):935. doi: 10.1016/j.athoracsur.2018.03.037. Epub 2018 Apr 19.

Authors

Edward K L Chan¹, Luis E C Andrade²

Affiliations

¹ Department of Oral Biology, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610-0424; Autoantibody Standardization Committee, International Union of Immunological Societies. Electronic address: [email protected].
² Rheumatology Division, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil; Quality Assessment and Standardization Committee, International Union of Immunological Societies.

PMID: 29679532
DOI: 10.1016/j.athoracsur.2018.03.037

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
Carcinoma, Non-Small-Cell Lung*
DNA
DNA Topoisomerases, Type I
DNA Topoisomerases, Type II
Humans
Lung Neoplasms*

Substances

Biomarkers
DNA
DNA Topoisomerases, Type I
DNA Topoisomerases, Type II